View Author
patient tumor bladder mutation recurrence cancer urine fgfr 3 mutations analysis study progression sample surveillance bladder cancer fgfr 3 carcinoma urine samples factor response marker detection cystoscopy result grade survival eortc table tumour urothelial urology tumor cells treatment bacillu recurrence risk score van der kwast expression eortc risk scores calmette-guerin eortc risk score prostate assay sensitivity growth bcg response level bladder tumors stage european nmibc receptor disease therapy follow-up zwarthoff ec polymorphism urothelial carcinoma maintenance number cytokine zwarthoff fgfr 3 mutation ficial bladder cancer transurethral resection tissue value prostate tumors modi fied surveillance 1.5 cm 1.5 month urine tests recurrence-free survival group broblast prognostic intravesical –muscle bladder cancer bcg treatment bacillus calmette-guerin
7 Most Recent Publications
|
FGFR3 Mutation Analysis in Voided Urine Samples to Decrease Cystoscopies and Cost in Nonmuscle Invasive Bladder Cancer Surveillance: A Comparison of 3 Strategies
(Article)
Kessel, K.E.M. van Kompier, L.C. Bekker-Grob, E.W. de Zuiverloon, T.C.M. Vergouwe, Y. Zwarthoff, E.C. Steyerberg, E.W. |
2013-03-22
|
|
Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: A systematic review
(Article)
Zuiverloon, T.C.M. Nieuweboer, A.J.M. Vékony, H. Kirkels, W.J. Bangma, C.H. Zwarthoff, E.C. |
2012-01-01
|
|
Optimization of nonmuscle invasive bladder cancer recurrence detection using a urine based FGFR3 mutation assay
(Article)
Zuiverloon, T.C.M. Tjin, S.S. Busstra, M. Bangma, C.H. Boeve, E.R. Zwarthoff, E.C. |
2011-08-01
|
|
No evidence of FGFR3 mutations in prostate cancer
(Article)
Zuiverloon, T.C.M. Boormans, J.L. Trapman, J. Leenders, G.J. van Zwarthoff, E.C. |
2011-05-01
|
|
Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer
(Article)
Rhijn, B.W.G. van Zuiverloon, T.C.M. Vis, A.N. Radvanyi, F. Leenders, G.J. van Ooms, B.C.M. Kirkels, W.J. Lockwood, G.A. |
2010-09-01
|
|
Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle - Invasive bladder cancer
(Article)
Zuiverloon, T.C.M. Aa, M.N.M. van der Kwast, Th.H. van der Steyerberg, E.W. Roozenbeek, B. Bangma, C.H. Zwarthoff, E.C. |
2010-06-01
|
|
In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: A case report
(Article)
Zuiverloon, T.C.M. Abas, C.S. Keur, K.A. van der Vermeij, M. Tjin, S.S. Tilborg, A.G. van Busstra, M. Zwarthoff, E.C. |
2010-03-30
|
